Drug Co. Hit With Class Action Over FDA Approval Claims
Eagle Pharmaceuticals Inc. was slapped with a securities class action in New Jersey federal court Tuesday, alleging investors paid artificially inflated stock prices this year due to the company's false and...To view the full article, register now.
Already a subscriber? Click here to view full article